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Allergic airways inﬂammationThe activation of C-ﬁbers in the airways induces coughing, mucus production and bronchoconstriction, which
are also symptoms of airway diseases. In this study, we evaluated the role of the C-ﬁbers and the TRPV1
(transient receptor potential vanilloid 1) receptor in an experimental mouse model of allergic airway
inﬂammation. To study the role of C-ﬁbers, we either degenerated the C-ﬁbers persistently (capsaicin
administration in neonate mice) or transiently (capsaicin administration in adult mice). No alteration was
observed in eosinophil recruitment to the bronchoalveolar lavage ﬂuid in animals treated with capsaicin in
the neonatal period. However, in adult animals, capsaicin treatment after the ﬁrst ovalbumin challenge (in the
establishment of the inﬂammatory process) decreased the eosinophil numbers. This effect was more
pronounced in adult animals treated with capsaicin before beginning the ovalbumin immunization (in the
development of the inﬂammatory process). In addition, interleukin (IL)-5 and chemokine ligand 11 (CCL11)
levels in the bronchoalveolar lavage ﬂuid, as well as P-selectin expression and p65 nuclear factor κB (NF-κB)
activation in the lung were also decreased. No alterations were observed in the IL-10 and IL-13 levels. Next we
determined the effect of TRPV1 receptor blockade on allergic airway inﬂammation. SB366791 administrated
inmice by intraperitoneal (500 μg/kg) or intranasal (0.1, 1 or 10 nmol/site) route failed to decrease eosinophil
recruitment to the bronchoalveolar lavage ﬂuid or alter any other metrics cited above. Thus, the present
results conﬁrm and extend previous data supporting the involvement of C-ﬁbers, but not the TRPV1 receptor,
in allergic airway inﬂammation.logia, Universidade Federal de
o D, CCB, Caixa Postal 476,
: +55 48 3721 9491; fax: +55
terra.com.br (J.B. Calixto).
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Allergic asthma is a complex inﬂammatory disorder characterized
by airway hyperresponsiveness, eosinophilic inﬂux and the hyperse-
cretion of mucus by goblet cells. This disease is frequently accompa-
nied by high serum levels of immunoglobulin (Ig) E and by
intrapulmonary production of certain interleukins such as interleukin
(IL)-4, IL-5 and IL-13 by allergen-speciﬁc T-helper 2 (Th2) cells
(Murphy and O'Byrne, 2010). Integrated signaling events between
IL-4 and IL-13 are thought to regulate pulmonary eosinophilia by
stimulating eosinophil-speciﬁc adhesion pathways and by modulat-
ing the local production of both IL-5 and CCL11 (eotaxin), which in
turn selectively drive eosinophil recruitment. IL-5, in particular, plays
a critical role in the regulation of bone marrow and blood eosinophilia
(Foster et al., 2001).The airways are innervated by branches of the trigeminal and
vagal afferents nerves (nodose and jugular ganglia). The majority
(75%) of afferent innervations of the respiratory tract are broncho-
pulmonary afferent C-ﬁbers (Coleridge and Coleridge, 1984; Lee,
2006). In the airways, C-ﬁbers are located in the mucosa, in the lung
parenchyma and in the space between epithelial cells (Adriaensen
et al., 1998; Watanabe et al., 2006). These ﬁbers respond to thermal,
chemical (such as capsaicin, the principal pungent ingredient of red
pepper) and acidic stimuli. In addition, cigarette smoke, air pollutants
and endogenous inﬂammatory mediators are also C-ﬁber stimuli (Ho
et al., 2001). Capsaicin stimulates afferent C-ﬁbers by activating the
transient potential receptor vanilloid 1 (TRPV1). In addition to the
expression of TRPV1 on sensory ﬁbers, the TRPV1 receptor is also
expressed in airway smooth muscle cells, epithelial cells, vascular
endothelial cells and submucosal glands as well as in inﬂammatory
cells (Agopyan et al., 2004; Jia and Lee, 2007; Ni et al., 2006; Reilly
et al., 2003; Seki et al., 2006; Watanabe et al., 2005). TRPV1 receptor
activation induces the release of neuropeptides such as neurokinins,
calcitonin gene-related peptide (CGRP) and substance P. These
neuropeptides are known to elicit neurogenic inﬂammation in the
airways by inducing potent effects on cells of the respiratory tract
(Barnes et al., 1991) and on inﬂammatory cells (Barnes, 1990).
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other TRP members, such as TRPA1 (transient receptor potential
ankyrin 1), in the airways and the relationship between these ion
channels and airways diseases has dramatically increased in the last
decade. Patients with chronic cough, for example, show an increased
number of TRPV1 immunoreactive axons (Groneberg et al., 2004). It
has also been reported that in asthmatic patients, treatment with a
cyclooxygenase 2 (COX-2) inhibitor attenuated the cough reﬂex
sensitivity in the airways to inhaled capsaicin (Ishiura et al., 2009).
Despite the growing number of studies, the involvement of C-ﬁbers
and TRPV1 in airway inﬂammation is not entirely clear. Therefore, the
present study was carried out to evaluate the role of C-ﬁbers and the
TRPV1 receptor in a murine model of allergic airway inﬂammation
induced by allergen (ovalbumin).
2. Materials and methods
2.1. Animals
Experiments were conducted using female BALB/c mice (8 weeks,
weighing 20–25 g). The administration of capsaicin or vehicle in
neonatal mice was performed on postnatal day 2, and the animals
were used at adult ages. Mice were kept in a room with controlled
temperature (22±2 °C) and humidity (60–80%) under a 12:12 h
light–dark cycle (lights on at 06:00 h). At appropriate time intervals,
mice were killed by an isoﬂurane overdose. The animals were put in
an acrylic chamber, and a controlled amount of the gas anesthetic was
added to the oxygen (2% isoﬂurane in O2) that was ﬂowing through
the machine. All of the procedures used in the present study complied
with the guidelines on animal care of the UFSC Ethics Committee on
the Use of Animals (protocol number PP00154), which follows the
Guide for the Care and Use of Laboratory Animals (DHEW [DHHS]
publication no. [NIH] 85–23, rev. 1996, Ofﬁce of Science and Health
Reports, DRR/NIH, Bethesda, MD 20205, U.S.A.).
2.2. Antigen immunization, booster and airway challenge
Mice (8 weeks old) were immunized on days 0 and 7 by subcu-
taneous injection of 4 μg ovalbumin plus 1.6 mg aluminumhydroxide in
0.4 mL saline. Next the animals were challenged twice by intranasal
route (on post-immunization days 14 and 21) with 10 μg ovalbumin in
50 μL saline, which was delivered into the nostrils under gaseous
anesthesia (2% isoﬂurane in O2), with the aid of a micropipette. The
control group consisted of non-immunized mice that received two
intranasal instillations of ovalbumin (on days 14 and 21). Animals were
killed 24 h after the secondovalbumin challenge (onpost-immunization
day 22), and the bronchoalveolar lavage ﬂuids or lungs were collected
(Rogerio et al., 2009).
2.3. Neonatal capsaicin treatment
Mice were given capsaicin (50 mg/kg, s.c.) or vehicle alone (1:1:8
vol/vol/vol ethanol-Tween 80-saline) at postnatal day 2, as previously
described (Jancso et al., 1977). Next, adult animals (8 weeks after
capsaicin pretreatment)were ovalbumin-immunized and -challenged
as described above. To assess whether a complete degeneration of the
C-ﬁbers had occurred after neonatal treatment with capsaicin, the
animals were ﬁrst submitted to an eye-wiping test (Ikeda et al., 2001)
1 day before the second ovalbumin challenge (on post-immunization
day 20, ~11 weeks after the capsaicin administration). For this test,
20 μl of a 0.01% capsaicin solution was administered to the eye, and
the number of wiping movements that occurred for 1 min was
counted. The maximal ﬁnal concentration of ethanol in this solution
was 0.001%, and it had no effect per se. The adult animals that wiped
their eyes no more than ﬁve times were considered to have beendesensitized by the neonatal capsaicin treatment, and the others were
not used in further experiments.
2.4. Capsaicin treatment in adult animals
Mice (8 weeks old) received 25 mg/kg capsaicin subcutaneously
on day 1 and 75 mg/kg on day 2 (both diluted in the proportion 1:1:8
vol/vol/vol ethanol-Tween 80-saline). For each day of treatment with
capsaicin, the animals were pretreated with theophylline (100 mg/kg,
s.c.) and terbutaline (1 mg/kg, i.p.) diluted in saline. After 30 min, the
animals were anesthetized with isoﬂurane and then received
capsaicin or vehicle (1:1:8 vol/vol/vol ethanol-Tween 80-saline)
(Morris et al., 2003; Symanowicz et al., 2004). The capsaicin treatment
in adult animals was done in two different periods. Animals allocated
to the ﬁrst period were injected with capsaicin on day 14 (30 min
after the ﬁrst ovalbumin challenge) and on day 15 after the ﬁrst
immunization. Animals allocated to the second period were injected
with capsaicin during the 2 days before initiating the ﬁrst ovalbumin
immunization. To assess whether desensitization of the C-ﬁbers had
occurred, the animals were ﬁrst submitted to an eye-wiping test as
described above 1 day before the second ovalbumin-challenge (on
post-immunization day 20).
2.5. Treatment with TRPV1 antagonist SB 366791
Two protocols were carried out to evaluate the participation of the
TRPV1 receptor in the allergic airway inﬂammatory model. For these,
SB366791 (a TRPV1 selective antagonist) was dissolved in dimethyl
sulfoxide (DMSO). In the ﬁrst protocol, animals were treated by
intraperitoneal route with SB366791 (500 μg/kg) or its vehicle (DMSO
0.2%) (Varga et al., 2005) 1 h before the second ovalbumin challenge
(day 21 after theﬁrst ovalbumin immunization). In the secondprotocol,
SB366791 was administered directly into the lungs of the mice by the
intranasal route (0.1, 1 or 10 nmol/site, 50 μL, 1 h prior and 5, 11, 17, and
23 h after exposure to the second ovalbumin challenge) (Kassuya et al.,
2008). An ovalbumin-immunized and -challenged mice group was
treated with vehicle (DMSO 0.2%) by the same route and timing as
described above.
2.6. Evaluation of leukocyte inﬂux into the bronchoalveolar space
Micewere killed by isoﬂurane overdose. A polyethylene cannulawas
subsequently introduced into the trachea, and phosphate-buffered
saline (PBS) containing heparin (10 UI/ml) was instilled in three
aliquots (0.3, 0.3 and 0.4 mL) for a total of 1 mL. The bronchoalveolar
lavage ﬂuid was recovered and placed on ice. Total cell and differential
leukocyte counts were made according a previous study (Rogerio et al.,
2009). Following centrifugation (400×g, 5 min, 4 °C), supernatants of
the bronchoalveolar lavage ﬂuids were collected and stored at−70 °C
for subsequent cytokine and chemokine determinations.
2.7. Measurement of IL-5, IL-10, IL-13 and CCL11
The IL-5, IL-10, IL-13 and CCL11 levels were assayed according to
the manufacturer's instructions (R&D Systems: Minneapolis, USA) by
speciﬁc ELISA (RayBiotech: Georgia, USA). The sensitivities were
N10 pg/mL.
2.8. Immunohistochemical studies
The animals were intracardially perfused with 4% of the ﬁxative
solution formaldehyde in 0.1 M phosphate buffer (pH 7.4). Lungs were
removed, post-ﬁxed for 24 h in the same solution, placed in ethanol
(70% v/v) and then submerged in parafﬁn. Tissues embedded in parafﬁn
were cut into thick sections (5-μm). Slides were deparafﬁnized through
a series of xylene baths and rehydrated through graded alcohol
Fig. 1. Effect of capsaicin treatment on eosinophil recruitment to the bronchoalveolar
lavage ﬂuid in neonatal mice (A), adult mice after the ﬁrst ovalbumin challenge (B) and
adult mice before the ﬁrst immunization (C) in an experimental allergic airway
inﬂammation model. Control groups were treated with vehicle or capsaicin but were
not ovalbumin-immunized. Samples were collected 24 h after the second ovalbumin
challenge. Values are presented as the mean±S.E.M. (n=6 per treatment). *Pb0.05
compared with control+vehicle group versus ovalbumin+vehicle group; #Pb0.05
compared ovalbumin+vehicle group versus ovalbumin+capsaicin group.
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immersion of the slides in a water bath at 95–98 °C in 10 mM trisodium
citrate buffer, pH 6.0, for 45 min. After overnight incubation at 4 °Cwith
primary antibody [polyclonal rabbit anti-phospho-p65 NF-κB (1:100,
Cell Signaling Technology, Massachusetts, USA) or polyclonal goat anti-
P-selectin (1:2000, Santa Cruz Biotechnology, California, USA)], the
slides were washed with PBS and incubated with the secondary
antibody Envision plus (DakoCytomation, California, USA), for 1 h at
room temperature. The sections were washed in PBS, and the
visualization was completed by use of 3,3′-diaminobenzidine (DAB)
(DakoCytomation) in chromogen solution and light counterstaining
with Harris's hematoxylin solution (Merck, Darmstadt, Germany).
Images were obtained with a microscope (Nikon Eclipse 50i) and
Digital Sight Camera (DS-5M-L1, Nikon, New York, USA). Control and
experimental tissues were placed on the same slide and processed
under the same conditions. Settings for image acquisitionwere identical
for control and experimental tissues. For eachmouse lung, three images
were obtained. The images were transferred to a computer, and the
average pixel color intensity of phospho-p65 NF-κB or P-selectin
staining was calculated as described in a previous study (Rogerio
et al., 2009).
2.9. Statistical analysis
The data are reported as the mean±S.E.M. The means from
different treatments in each individual experiment were compared by
ANOVA. When signiﬁcant differences were identiﬁed, individual
comparisons were subsequently made with Tukey's test. Values of
Pb0.05 were considered to be statistically signiﬁcant.
2.10. Drugs and reagents
The following drugs were used: capsaicin, aluminum hydroxide,
ovalbumin, theophylline and terbutaline (Sigma Chemical: Missouri,
USA), SB366791 (Tocris Cookson Inc., Mississippi, USA), isoﬂurane
(anaesthesic, Forane®, Abbott: Abbott Park, USA), and heparin
(anticoagulant, Liquemine®, Roche: Basel, Switzerland). The reagents
Tween-80 (Merck: Darmstadt, Germany), DMSO and ethanol were
purchased from Vetec Química Fina (Rio de Janeiro, Brazil).
3. Results
3.1. Effect of neonatal capsaicin treatment on leukocyte numbers in the
bronchoalveolar lavage ﬂuid
Because no difference in neutrophil and mononuclear cell inﬂux
after afferent denervation was observed in either neonatal or adult
animals (data not shown), we will focus on eosinophil numbers. The
control mice (non-immunized) that were treated in the neonatal
period with capsaicin or with vehicle did not present eosinophils in
the bronchoalveolar lavage ﬂuid (Fig. 1A). However, mice that were
treated during the neonatal period with capsaicin or its vehicle and
were ovalbumin-immunized and then ovalbumin-challenged showed
an increase of eosinophil numbers in the bronchoalveolar lavage ﬂuid
when compared with the respective control group (Fig. 1A). No
signiﬁcant difference was observed between mice treated with
vehicle or capsaicin and ovalbumin-immunized and -challenged.
3.2. Effect of capsaicin treatment in adult animals in the allergic airway
inﬂammatory model
To investigate the effect of the depletion of neuropeptide stores
induced by capsaicin injection in adult mice, we used two different
protocols: mice allocated to the ﬁrst protocol started the capsaicin
treatment 30 min after the ﬁrst ovalbumin challenge (seeMethods). No
eosinophils were found in the bronchoalveolar lavage ﬂuid of thecontrol adult mice (non-immunized) treated with either vehicle or
capsaicin (Fig. 1B). Ovalbumin-immunized and -challenged mice
treated with vehicle showed an increase in the eosinophil recruitment
to the bronchoalveolar lavage ﬂuid compared to the non-immunized
vehicle-treated group. Capsaicin-treated and ovalbumin-immunized
and -challenged mice exhibited a signiﬁcant decrease in eosinophil
recruitment to the bronchoalveolar lavage ﬂuid when compared with
the vehicle-treated and ovalbumin-immunized and -challenged mice.
Eosinophil numbers decreased by approximately 59% from 1.47±
0.27×106 cells/mL (vehicle) to 0.47±0.23×106 cells/mL (capsaicin)
(mean±S.E.M., pb0.05) (Fig. 1B).
Animals allocated to the second protocol received capsaicin for
2 days before the ﬁrst ovalbumin-immunization. Vehicle-treated and
ovalbumin-immunized and -challenged mice exhibited a signiﬁcant
increase in eosinophil recruitment to the bronchoalveolar lavage ﬂuid
when compared with the vehicle-treated and non-immunized group
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treated and ovalbumin-immunized and -challenged mice exhibited a
signiﬁcant decrease in eosinophil recruitment to the bronchoalveolar
lavage ﬂuid when compared with the vehicle-treated and ovalbumin-
immunized and -challenged mice. Eosinophil numbers were de-
creased by approximately 88% from 0.7±0.14×106 cells/mL (vehicle)
to 0.08±0.02×106 cells/mL (capsaicin) (mean±S.E.M., pb0.05)
(Fig. 1C).
3.3. IL-5, CCL11, IL-10 and IL-13 levels in the bronchoalveolar lavageﬂuid of
adult animals treated with capsaicin before beginning the immunization
process with ovalbumin
Next, we assessed the IL-5, CCL11, IL-10 and IL-13 levels in the
bronchoalveolar lavageﬂuid of the adult animals allocated to the second
treatment protocol with capsaicin because this protocol was more
efﬁcient in decreasing the eosinophil recruitment to the bronchoalveo-
lar lavage ﬂuid. No signiﬁcant alteration was observed in IL-5, CCL11,
IL-10 and IL-13 levels in the bronchoalveolar lavage ﬂuid of control
(non-immunized) animals treated with capsaicin compared to animals
treated with vehicle (non-immunized) (Fig. 2). In agreement with the
increase of eosinophil recruitment found in the bronchoalveolar lavage
ﬂuid, animals thatwere vehicle-treated and ovalbumin-immunized and
-challenged showed a signiﬁcant increase in the levels of IL-5, CCL11,
IL-10 and IL-13 in the bronchoalveolar lavage ﬂuid, when assessed 24 h
after the second ovalbumin-challenge compared to vehicle-treated and
non-immunized animals (Fig. 2A–D). Capsaicin-treated and ovalbumin-
immunized and -challenged mice showed signiﬁcantly decreased IL-5
and CCL11 levels when compared with the vehicle-treated and
ovalbumin-immunized and -challenged mice. IL-5 levels were de-
creased by approximately 91% from 296.16±47.52 pg/mL (vehicle) to
25.93±12.02 pg/mL (capsaicin) (mean±S.E.M., pb0.05) (Fig. 2A).Fig. 2. Effect of the depletion of neuropeptides by capsaicin treatment on IL-5 (A), CCL11 (B),
ﬁrst immunization with ovalbumin. Control groups were treated with vehicle or capsaicin
ovalbumin challenge. Values are presented as the mean±S.E.M. (n=6 per treatment). *Pb0
compared ovalbumin+vehicle group versus ovalbumin+capsaicin group.CCL11 levels were decreased by approximately 52% from 20.29±
3.68 pg/mL (vehicle) to 8.02±0.94 pg/mL (capsaicin) (mean±S.E.M.,
pb0.05) (Fig. 2B). However, no alterationwas observed in the IL-10 and
IL-13 levels between these groups (Fig. 2C and D).
3.4. Effect of the capsaicin treatment in adult animals on NF-κB activation
and P-selectin expression in the lung
We then assessed the effect of the depletion of neuropeptides in
adult animals submitted to the second treatment protocol with
capsaicin (before beginning the immunization process with ovalbu-
min) on the expression of P-selectin and the phosphorylation state of
the p65 NF-κB subunit by means of an immunohistochemistry
technique.
Constitutive P-selectin expression was observed in vehicle-treated
mice or in capsaicin-treated and non-immunized mice (Fig. 3). In the
vehicle-treated and ovalbumin-immunized and -challenged group,
we observed an upregulation of P-selectin expression along the
bronchial epithelium. Capsaicin-treated and ovalbumin-immunized
and-challengedmiceexhibitedadecrease inP-selectin expressionwhen
compared with the vehicle-treated and ovalbumin-immunized and
-challengedmice. P-selectin expressionwasdecreasedbyapproximately
37% from 53.20±5.89 arbitrary units (vehicle) to 33.54±2.56 arbitrary
units (capsaicin) (mean±S.E.M., pb0.05) (Fig. 3).
No alteration in the phosphorylation state of the p65 NF-κB subunit
was found in the nucleus of the lung cells of vehicle-treated and non-
immunized animals. A discrete staining was observed in capsaicin-
treated and non-immunized animals. In the bronchial epithelium of
vehicle-treated and ovalbumin-immunized and -challenged mice, we
observed the activation of the p65 NF-κB subunit when compared to
vehicle-treated and non-immunized animals. Capsaicin-treated and
ovalbumin-immunized and -challenged mice exhibited a decrease inIL-10 (C) and IL-13 (D) levels in the bronchoalveolar lavage ﬂuid of adult mice before the
but were not ovalbumin-immunized. Samples were collected 24 h after the second
.05 compared with control+vehicle group versus ovalbumin+vehicle group; #Pb0.05
Fig. 3. Effect of the depletion of neuropeptides by capsaicin treatment in adult mice on
P-selectinexpressionbefore theﬁrst immunizationwithovalbumin. Representative images
of P-selectin immunohistochemistry staining of the control+vehicle (A), control+
capsaicin (B), ovalbumin+vehicle (C) and ovalbumin+capsaicin (D) groups (magniﬁca-
tion: ×200). Themean intensity of P-selectin stainingwas determined from image analysis
and is represented as arbitrary units (E). Control groups were treated with vehicle or
capsaicin but were not ovalbumin-immunized. Values are the mean±S.E.M. (n=3 per
group) for immunohistochemistry analysis. *Pb0.05 compared with control+vehicle
group versus ovalbumin+vehicle group; #Pb0.05 compared ovalbumin+vehicle group
versus ovalbumin+capsaicin group.
Fig. 4. Effect of the depletion of neuropeptides by capsaicin treatment in adultmice on the
activation of p65 NF-κB before the ﬁrst immunization. Representative images of phospho-
p65 NF-κB immunohistochemistry staining of the control+vehicle (A), control+
capsaicin (B), ovalbumin+vehicle (C) and ovalbumin+capsaicin (D) groups (magniﬁ-
cation: x 200). Themean intensity of p65 NF-κBwas determined from image analysis and
is represented as arbitrary units (E). Control groupswere treatedwith vehicle or capsaicin
but were not ovalbumin-immunized. Values are the mean±S.E.M. (n=3 per group) for
immunohistochemistry analysis. *Pb0.05 compared with control+vehicle group versus
ovalbumin+vehicle group; #Pb0.05 compared ovalbumin+vehicle group versus
ovalbumin+capsaicin group.
Fig. 5. Effect of intranasal treatment with SB366791 (0.1, 1 or 10 nmol/site) on the
recruitment of eosinophils to the bronchoalveolar lavage ﬂuid of ovalbumin-
immunized and -challenged mice. An ovalbumin-immunized and -challenged mice
group was treated with vehicle (DMSO 0.2%). Control groups were treated with vehicle
but were not ovalbumin-immunized. Samples were collected 24 h after the second
ovalbumin-challenge. Values are presented as the mean±S.E.M. (n=12 per treat-
ment). *Pb0.05 compared with control group.
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ovalbumin-immunized and -challenged mice. The p65 NF-κB expres-
sion was decreased by approximately 62% from 7.53±1.30 arbitrary
units (vehicle) to 2.81±0.05 arbitrary units (capsaicin) (mean±S.E.M.,
pb0.05) (Fig. 4).
3.5. Effect of the TRPV1 receptor antagonist SB366791 on the allergic
airways inﬂammatory model
In view of the protective actions of depletion of neuropeptides by
capsaicin in C-ﬁbers in the airways, we next determined the effect of
TRPV1 receptor (capsaicin receptor) blockade on allergic airway
inﬂammation. Ovalbumin-immunized and -challenged mice that were
treatedwith vehicle or untreated showed increased eosinophil numbers
in the bronchoalveolar lavage ﬂuid when compared with the control
group. No signiﬁcant alteration in eosinophil recruitment to bronch-
oalveolar lavage ﬂuid was observed in the ovalbumin-immunized and
-challenged mice that were treated with SB366791 by intraperitoneal
(500 μg/kg; data not shown) or intranasal (0.1, 1 or 10 nmol/site) route
when compared to ovalbumin-immunized and -challenged mice
treated with vehicle (Fig. 5). In addition, the treatment with SB
366791 (10 nmol/site, intranasal route) did not reduce IL-5 and CCL11
levels in the bronchoalveolar lavageﬂuid and did not alter the P-selectin
expression and the p65 NF-κB activation in the lung (data not shown).
4. Discussion
Here, we have provided evidence of the anti-inﬂammatory
actions induced by the depletion of neuropeptides in adult animals,
but not the degeneration of C-ﬁbers, in neonate mice in allergicairways responses.When given before ovalbumin-immunization and
-challenge, capsaicin blocked the development of allergic airway
responses. The responsiveness to capsaicin in desensitized adult
60 A.P. Rogerio et al. / European Journal of Pharmacology 662 (2011) 55–62animals regulated the eosinophilia with marked decreases in the
levels of IL-5 (an important Th2 cytokine that serves as a
chemoattractant and activator of eosinophils) and CCL11 (a selective
chemokine of eosinophils). In addition, P-selectin (an adhesion
molecules involved in leukocyte control including eosinophils)
expression in the lung was also decreased; these changes were
associatedwith the inhibition of NF-κB pathways. TRPV1 appears not
to be required for allergic airway inﬂammation, suggesting that other
receptors expressed in C-ﬁbers, such as the TRPA1,might be involved
in asthma development.
Research regarding the role of C-ﬁbers and the TRPV1 receptor in
pathological conditions of the airways has had recent developments
(Caceres et al., 2009; Jia and Lee, 2007; Watanabe et al., 2008). When
airway C-ﬁbers are activated by several stimuli (e.g., capsaicin,
bradykinin, tobacco smoke, allergens, ozone and inﬂammatory
mediators), these ﬁbers release numerous mediators, including
neuropeptides such as substance P, neurokinin A and CGRP (Barnes,
2001), which in turn cause inﬂammatory effects in the airways. Thus,
these neuropeptides play an important role in human respiratory
diseases, such as asthma, because they exert critical effects on airway
smooth muscle, secretory glands and the airway epithelium. More-
over, they also act on inﬂammatory and immune cells by inducing the
release of several lipids (e.g., prostaglandins) in addition to the pro-
inﬂammatory cytokines (Rogers, 1995; Reynolds et al., 1997) and by
inducing chemotaxis (Dunzendorfer and Wiedermann, 2000).
Eosinophilia is a hallmark of parasitic and allergic diseases.
Eosinophils are important sources of cytokines, chemokines, lipid
mediators (Rothenberg and Hogan, 2006) and cationic proteins,
which are involved in the pathophysiology of asthma (Kubo et al.,
1999). In addition, eosinophils release nerve growth factor (NGF) and
neuropeptides such as substance P (Garland et al., 1997) that are known
to activate and sensitize the C-ﬁbers. Therefore, there is a putative
positive feedback loop between eosinophils and C-ﬁbers in the
development and maintenance of the pathophysiology of asthma. The
present results show that the degeneration of primary afferent C-ﬁbers
by capsaicin treatment in neonate animals submitted to allergic airway
inﬂammation did not cause a signiﬁcant alteration to eosinophil
recruitment to the bronchoalveolar lavage ﬂuid compared to vehicle-
treated mice submitted to allergic airway inﬂammation. Nonetheless,
the temporary depletion of sensory neuropeptide stores caused by
capsaicin administration in adult animals, either before the ovalbumin
immunization or during the ovalbumin challenge phase, resulted in a
marked decrease in eosinophil recruitment to the bronchoalveolar
lavage ﬂuid, which conﬁrmed and extended a previous study
(Alessandri et al., 2003). These results demonstrate the inﬂammatory
role of C-ﬁbers in primary systemic sensitization aswell as inpulmonary
antigenic challenge. The differences in the effect in the neonatal
(degeneration of C-ﬁbers) and adult mice (temporary depletion of
C-ﬁbers) might be related to the fact that in neonatal animals, a
compensatory mechanism may induce a phenotypic alteration in
sensoryﬁbers speciﬁcally neuropeptides-free ﬁbers, as primary afferent
neurons of nodose ganglion, which might contribute to neuropeptides
production (Fischer et al., 1996). In contrast, the responsiveness to
capsaicin in desensitized adult animals (in our protocol) is markedly
reduced for at least 5 weeks (Morris et al., 2003; Symanowicz et al.,
2004), and the short time between the temporary depletion, the
inﬂammation and the end of experiment (3 weeks) is not sufﬁcient to
permit the C-ﬁbers to have normal neuropeptide stores.
Next, we showed, for the ﬁrst time, that the depletion of
neuropeptide stores by capsaicin in adult mice reduced the concentra-
tion of IL-5 and CCL11 in the bronchoalveolar lavage ﬂuid. IL-5 is
essential for eosinophil migration from the bone marrow to the blood
(Faccioli et al., 1996; Rogerio et al., 2003) and speciﬁcally supports
terminal differentiation and proliferation of eosinophil precursors as
well as activating mature eosinophils (Clutterbuck and Sanderson,
1988; Coefﬁer et al., 1991; Sanderson et al., 1985; Yamaguchi et al.,1988). Early studies have shown the important role played by CCL11 in
eosinophil recruitment to tissues during certain physiological and
inﬂammatory conditions (Shinkai et al., 1999; Zimmermann et al.,
2000). In fact, CCL11 cooperates with IL-5 in the induction of tissue
eosinophilia (Zimmermann et al., 2003). Thesemediators have a central
role in the eosinophil biology of allergic diseases, and their consequent
reduction is associated with the control of allergic inﬂammation, as was
observed in the adult animals that were treated with capsaicin and
ovalbumin-immunized and -challenged.
Previous studies demonstrated that IL-10 exhibits key regulatory
effects on immune activation, including Th2 cell, mast cell, and
eosinophil activation. IL-10 also serves as a key effector of regulatory
T cell activity (Lloyd andHawrylowicz, 2009; Royer et al., 2001). IL-13 is
also involved in the pathophysiology of asthma: regulation of IgE
synthesis, mucus hypersecretion, subepithelial ﬁbrosis and eosinophil
inﬁltration. However, in our results, no differences were observed
concerning the concentrations of IL-10 and IL-13 in the capsaicin-
treated adult animals and ovalbumin-immunized and -challenged
compared to the vehicle-treated animals and ovalbumin-immunized
and -challenged, which suggests that the anti-eosinophilic effect of the
depletion of neuropeptide stores by capsaicin in adult mice is IL-10 and
IL-13 independent.
As there is a great amount of evidence indicating that adhesion
molecules are critically involved in leukocyte control, we next
evaluated the expression of P-selectin in the lungs, which is also
considered to be an important target for modulating eosinophilic
inﬂux to the inﬂammatory tissue (Wardlaw, 2001). Our ﬁndings
revealed that the depletion of neuropeptides by capsaicin in adult
animals consistently decreased the expression of P-selectin in the
bronchial epithelium of ovalbumin-immunized and -challenged mice.
Therefore, the reported inhibition of P-selectin expression is expected
to contribute to anti-inﬂammatory actions.
Evidence suggests that in certain allergic diseases, the expression
of some relevant genes encoding chemokines (e.g., CCL11), cytokines
(e.g., IL-5) and adhesion molecules (e.g., P-selectin) is critically
regulated by NF-κB (Anrather et al., 1997; Rothenberg et al., 1995;
Yang et al., 1998). Therefore, the inhibition of NF-κB activation in the
lungs observed following neuropeptide store depletion in capsaicin-
treated adult animals in this study might be directly related to the
reduction of CCL11 and IL-5 levels in the bronchoalveolar lavage ﬂuid
and P-selectin expression in the lungs as well as the consequent
reduction in eosinophil recruitment to the bronchoalveolar lavage
ﬂuid.
Accumulated evidence shows that in the airways, the TRPV1
receptor (which is activated by capsaicin) is present in sensory nerves,
smooth muscle cells, epithelial cells, vascular endothelial cells,
submucosal glands and in inﬂammatory cells (Agopyan et al., 2004;
Jia and Lee, 2007; Ni et al., 2006; Reilly et al., 2003; Seki et al., 2006;
Watanabe et al., 2005). Animals treated intratracheally with capsaicin
increased the eosinophil,mainly neutrophil andmononuclear cell inﬂux
to the bronchoalveolar lavage ﬂuid. In addition, the recruitment of these
cells was prevented by pre-treatment with capsazepine, a TRPV1
receptor antagonist (Karmouty-Quintana et al., 2007). Concerning the
sensorial innervations of the airways, van den Worm et al. (van den
Worm et al., 2005) reported a decrease in the tracheal rings contraction
isolated from ovalbumin-immunized guinea pigs with capsazepine.
Moreover, capsazepine was able to prevent the activation of NF-κB in
lipopolysaccharide (LPS)-stimulated macrophages (RAW 267.4) (Oh et
al., 2001).
To evaluate the role of the TRPV1 receptor in eosinophilic
inﬂammation, we administrated SB366791, a TRPV1 selective antago-
nist, by intraperitoneal and intranasal routes. Both routes of treatment
with SB366791 did not signiﬁcantly decrease the eosinophil recruit-
ment in any othermetric (IL-5 and CCL11 levels aswell as P-selectin and
NF-κB expression) (data not shown). This result might be explained by
robust the Ca2+ inﬂuxes after nervous depolarization, triggering
61A.P. Rogerio et al. / European Journal of Pharmacology 662 (2011) 55–62neuropeptide release through other ionic channels present in the
C-ﬁbers innervating the airways. Further reinforcing this idea, a recent
study showed that vagal sensory neurons innervating the mouse lungs
express, in addition to TRPV1, the TRPA1 channels (Nassenstein et al.,
2008). Moreover, Caceres et al. (2009) have shown that the TRPA1
receptor blockade improves the phenotypes of allergic airway inﬂam-
mation induced by ovalbumin, whereas TRPV1 was not required.
In conclusion, the results presented here reveal that the depletion of
neuropeptides by capsaicin in adult animals, but not the degeneration of
C-ﬁbers in neonate mice, reduced some of the most important
phenotypes of allergic airway inﬂammation, namely eosinophil recruit-
ment, IL-5 and CCL11 levels in the bronchoalveolar lavage ﬂuid and
P-selectin expression in the lung, most probably through the modula-
tion of transcription factor NF-κB. Together, such results largely extend
previous ﬁndings and conﬁrm the anti-inﬂammatory activity of the
depletion of neuropeptides by capsaicin in C-ﬁbers, and they suggest
that TRPV1 might not contribute to the eosinophilic inﬂammatory
process in the allergic airway inﬂammation.Acknowledgments
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